These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29924723)

  • 21. Getting the message across: pathophysiology and signaling via receptors for polypeptide hormones and proteinases.
    Hollenberg MD
    Clin Invest Med; 2010 Apr; 33(2):E133. PubMed ID: 20370993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteinases, their receptors and inflammatory signalling: the Oxford South Parks Road connection.
    Hollenberg MD
    Br J Pharmacol; 2015 Jul; 172(13):3196-211. PubMed ID: 25521749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A human prostatic bacterial isolate alters the prostatic microenvironment and accelerates prostate cancer progression.
    Simons BW; Durham NM; Bruno TC; Grosso JF; Schaeffer AJ; Ross AE; Hurley PJ; Berman DM; Drake CG; Thumbikat P; Schaeffer EM
    J Pathol; 2015 Feb; 235(3):478-89. PubMed ID: 25348195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protease-activated receptors: regulation of neuronal function.
    Saito T; Bunnett NW
    Neuromolecular Med; 2005; 7(1-2):79-99. PubMed ID: 16052040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteinase-activated receptor-2 in the skin: receptor expression, activation and function during health and disease.
    Rattenholl A; Steinhoff M
    Drug News Perspect; 2008 Sep; 21(7):369-81. PubMed ID: 19259550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triggering of proteinase-activated receptor 4 leads to joint pain and inflammation in mice.
    McDougall JJ; Zhang C; Cellars L; Joubert E; Dixon CM; Vergnolle N
    Arthritis Rheum; 2009 Mar; 60(3):728-37. PubMed ID: 19248120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutrophil and pathogen proteinases versus proteinase-activated receptor-2 lung epithelial cells: more terminators than activators.
    Chignard M; Pidard D
    Am J Respir Cell Mol Biol; 2006 Apr; 34(4):394-8. PubMed ID: 16547194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate-specific kallikreins-2 and -4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and -2.
    Mize GJ; Wang W; Takayama TK
    Mol Cancer Res; 2008 Jun; 6(6):1043-51. PubMed ID: 18567807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protease-activated receptors, cyclo-oxygenases and pro-angiogenic signalling in endothelial cells.
    Wheeler-Jones CP; Farrar C; Garonna E
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1179-83. PubMed ID: 19909242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteinase-activated receptor pharmacology: trickier and trickier.
    Moffatt JD
    Br J Pharmacol; 2004 Oct; 143(4):441. PubMed ID: 15381632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteinase-activated receptor 2 activation in the airways enhances antigen-mediated airway inflammation and airway hyperresponsiveness through different pathways.
    Ebeling C; Forsythe P; Ng J; Gordon JR; Hollenberg M; Vliagoftis H
    J Allergy Clin Immunol; 2005 Mar; 115(3):623-30. PubMed ID: 15753914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proinflammatory signaling functions of thrombin in cancer.
    Ebrahimi S; Rahmani F; Behnam-Rassouli R; Hoseinkhani F; Parizadeh MR; Keramati MR; Khazaie M; Avan A; Hassanian SM
    J Cell Physiol; 2017 Sep; 232(9):2323-2329. PubMed ID: 28004386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protease-activated receptors: how proteases signal to cells to cause inflammation and pain.
    Bunnett NW
    Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():39-48. PubMed ID: 16673265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs).
    Oikonomopoulou K; Hansen KK; Saifeddine M; Vergnolle N; Tea I; Blaber M; Blaber SI; Scarisbrick I; Diamandis EP; Hollenberg MD
    Biol Chem; 2006 Jun; 387(6):817-24. PubMed ID: 16800746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone marrow-derived mesenchymal stem cells induced by inflammatory cytokines produce angiogenetic factors and promote prostate cancer growth.
    Yang KQ; Liu Y; Huang QH; Mo N; Zhang QY; Meng QG; Cheng JW
    BMC Cancer; 2017 Dec; 17(1):878. PubMed ID: 29268703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4.
    Swedberg JE; Nigon LV; Reid JC; de Veer SJ; Walpole CM; Stephens CR; Walsh TP; Takayama TK; Hooper JD; Clements JA; Buckle AM; Harris JM
    Chem Biol; 2009 Jun; 16(6):633-43. PubMed ID: 19549601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of IL-6 release from human T cells by PAR-1 and PAR-2 agonists.
    Li T; He S
    Immunol Cell Biol; 2006 Oct; 84(5):461-6. PubMed ID: 16869943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between Tumor Cell Surface Receptor RAGE and Proteinase 3 Mediates Prostate Cancer Metastasis to Bone.
    Kolonin MG; Sergeeva A; Staquicini DI; Smith TL; Tarleton CA; Molldrem JJ; Sidman RL; Marchiò S; Pasqualini R; Arap W
    Cancer Res; 2017 Jun; 77(12):3144-3150. PubMed ID: 28428279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the tissue factor pathway in the biology of tumor initiating cells.
    Garnier D; Milsom C; Magnus N; Meehan B; Weitz J; Yu J; Rak J
    Thromb Res; 2010 Apr; 125 Suppl 2():S44-50. PubMed ID: 20434004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kallikrein-related peptidase 4 induces cancer-associated fibroblast features in prostate-derived stromal cells.
    Kryza T; Silva LM; Bock N; Fuhrman-Luck RA; Stephens CR; Gao J; Samaratunga H; ; Lawrence MG; Hooper JD; Dong Y; Risbridger GP; Clements JA
    Mol Oncol; 2017 Oct; 11(10):1307-1329. PubMed ID: 28510269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.